News
-
-
REGULATED PRESS RELEASE
Air Liquide Q1 2025 Revenue
-
PRESS RELEASE
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx -
PRESS RELEASE
Succession planning secured in Bühler Group’s leadership
Bühler Group secures succession planning in leadership with upcoming appointment of Samuel Schär as new CEO and Stefan Scheiber as new Chairman. Long-term ownership strategy remains in the family, ensuring continuity and stability -
-
-
-
-
-